- About us
- A new Institute dedicated to combating Leukemia
- Medical-scientific program
- History of Hematology on the Saint-Louis Campus
- Institute Governance
- Press Room
- Contact us
- Our news
- Profile of Valéria Bisio, Research Officer
- Establishment of a Hemato-Oncogenetics Unit
- Profile of Alice Gros, a peer-support patient
- Laureates of the first call for projects of the Leukemia Institute
- Profile of Julien Calvo, researcher
- Support us
- Join us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Anti-cancer Treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Department of clinical hematology
- Department of adult hematology
- Hematology Transplant Unit
- Department of Pharmacology and Clinical Investigations
- Department of clinical hematology and cell therapy
- Adolescent and Young Adult Unit
- Outpatient Hemato-oncogenetics Unit
- Department of senior hematology
- Department of pediatric hematology and immunology
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient Information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Anti-cancer Treatments
- Supportive Care
- Psychological Support
- Research
- Our research teams
- Molecular pathology
- Functional precision medicine for leukemia
- Normal and pathological hematopoiesis
- Niche, Cancer, and Radiation in Hematopoiesis
- Population Evolution and Interaction Particle Systems
- Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Identification and targeting of extrinsic regulators of myeloid malignancies
- Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Molecular Mechanisms of Acute Myeloid Leukemia Development
- Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Leukemia & Niche Dynamics
- Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Stem cell dysfunction and secondary AML
- Biostatistics and clinical epidemiology
- Our technological platforms
- Our clinical research
Accueil » Hematology Medical Laboratory, Michaela FontenayHematology Medical Laboratory, Michaela Fontenay
...Pr Michaela Fontenay
Cochin Hospital – Port-Royal
27 rue du Fg Saint-Jacques
75014 Paris
Diseases
Acute myeloid leukemia
Myelodysplastic syndromes
Myeloproliferative syndromes
Lymphoma
Lymphoid malignancies
Multiple myeloma
VEXAS syndrome
Acute myeloid leukemia
Myelodysplastic syndromes
Myeloproliferative syndromes
Lymphoma
Lymphoid malignancies
Multiple myeloma
VEXAS syndrome
Department activities
The department is reference medical biology laboratory for the phenotypic and molecular diagnosis of myeloid malignancies and a referral laboratory of the diagnosis of VEXAS syndrome.
Multiparametric flow cytometry and next generation sequencing are used.
Our clinical research
The department has developed translational research on myeloid malignancies during health care and clinical trials based on multi-omics associating (epi)genomics (methyome), transcriptomics, proteomics.
The team is analyzing the immune ladscape of myeloid malignancies by flow cytometry and mass cytometry within the i4MDS consortium and contributes to the molecular profiling of VEXAS syndrome with the FRENVEX group.
Patient information
Team members
KOSMIDER OlivierPU-PH Université Paris Cité, Université Paris Cité, molecular oncohematologyCHAPUIS NicolasMCU-PH Université Paris Cité, celular oncohematology, immunologyALMIRE CarolePH, hematology and cellular oncohematologyBOUSSAID IsmaëlPHU Université Paris Cité, cellular and molecular oncohematologyFRIEDRICH ChloéPH, cellular and molecular oncohematologyFONTENAY MichaelaPU-PH, Head of translational research departmentFeatured research projects
Description and therapeutic targeting of the bone marrow microenvironment of VEXAS syndrome
Olivier KOSMIDER, PU-PH
Description of immune and cytokine landscape of myeloid malignancies and of other blood cancers upon immunotherapies
Nicolas CHAPUIS, MCU-PH
Integration of post-transcriptional regulations of gene expression in myeloid malignancies
Ismael BOUSSAID, PHU
Partners
Follow our actions by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To be cared for and supported
- A new Institute dedicated to combating Leukemia